Therefore, we speculate that AT-III is activated in the inflammatory response caused by the abnormal growth of endometrial tissue in EMs patients and plays an anti-inflammatory role by increasing its consumption within the vasculature. The gene discussed is SERPINC1; the disease is eosinophilia-myalgia syndrome.